Avanos Medical Inc (FRA:8HH)
€ 21.6 +0.20 (+0.93%) Market Cap: 1.03 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 1.49 GF Score: 62/100

Q1 2024 Avanos Medical Inc Earnings Call Transcript

May 02, 2024 / 01:00PM GMT
Release Date Price: €17.5 (+0.57%)

Key Points

Positve
  • Avanos Medical Inc (AVNS) reported first quarter results in line with expectations, showing a strong performance in digestive health and improvements in pain management and recovery.
  • Organic sales increased by 4.7% year-over-year, driven by strategic decisions to focus on higher return activities and effective supply chain management.
  • Adjusted EBITDA from continuing operations was $21 million, with adjusted diluted earnings per share at $0.22, indicating robust profitability.
  • The company successfully reduced its first quarter backorder levels significantly from over $8 million last year to about $1 million, demonstrating improved operational efficiency.
  • Avanos Medical Inc (AVNS) is making substantial progress on its three-year transformation priorities, which are expected to enhance financial performance and operational efficiency by 2025.
Negative
  • Sales in the pain management and recovery portfolio were down approximately 1% year-over-year, excluding certain benefits, due to strategic product discontinuations and foreign exchange impacts.
  • The company anticipates slower growth in the coming quarters for its new unit product line as it enters the late stages of in-pit adoption.
  • Free cash flow was negative $12 million in the first quarter, influenced by year-end payouts and one-time costs related to transformation efforts.
  • While there has been progress in the pain management portfolio, the first quarter performance has not yet reached the company's desired levels.
  • The company faces ongoing challenges with price volatility in its HA business, which could impact future financial stability despite mitigation strategies.
Operator

Good morning, ladies and gentlemen, and welcome to the Avanos First Quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded on Thursday, May 2, 2024.

I would now like to turn the conference over to Scott Galvan. Please go ahead.

Scott Galovan
Avanos Medical Inc - Senior Vice President, Strategy and M&A

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to Autodesk's 2024 first quarter Earnings Conference Call. Presenting today will be Joe Woody, CEO; and Michael Greiner, Senior Vice President, CFO, and Chief Transformation Officer.

Joe will review our first quarter results, the current business environment, as well as provide an update on our transformation efforts. Michael will share additional detail regarding these topics and affirm our 2024 planning assumptions, we will finish the call with Q&A.

The presentation for today's call is available on the Investors section of our website, avanos.com. As a reminder, our comments today contain forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot